688687.SS
Get informed when a big investor buys or sells
+ FollowOvervalued by 104.3% based on the discounted cash flow analysis.
| Market cap | $3.07 Billion |
|---|---|
| Enterprise Value | $2.90 Billion |
| Dividend Yield | $0.25 (1.36%) |
| Earnings per Share | $0.18 |
| Beta | 0.49 |
| Outstanding Shares | 167,435,395 |
| P/E Ratio | 305.5 |
|---|---|
| PEG | -6018.1 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 1.74 |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | 97.31 |
| Enterprise Value to Net Income | -5555 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.28 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Established in 2008 and based in Beijing, China, Beijing Kawin Technology Share-Holding Co., Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, with a primary emphasis on treatments for liver con...